Last reviewed · How we verify

NCT04692571: PSICON-B

EMG-Based Hand-Wrist Control: Study B Mirrored

Completed EARLY_PHASE1 Last updated 5 January 2021
What this trial tests

EARLY_PHASE1 trial testing PSICON Measurement Apparatus in Amputation in 20 participants. Completed in 24 August 2020.

Timeline
29 June 2017
Primary endpoint
24 August 2020
24 August 2020

Quick facts

Lead sponsorLiberating Technologies, Inc.
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsequential
Maskingnone
Primary purposebasic science
Enrollment20
Start date29 June 2017
Primary completion24 August 2020
Estimated completion24 August 2020
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Liberating Technologies, Inc.

Who can join

18 and older, any sex, with Amputation or Amputation; Traumatic, Hand. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study assessing four-channel prosthesis controller, that compares contralateral (mirrored) EMG-force training to ipsilateral EMG-target training with both limb-absent and able-bodied subjects

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Amputation

Currently open trials in the same condition.

Other Liberating Technologies, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04692571.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing